Development of 6-amido-4-aminoisoindolyn-1,3-diones as p70S6K1 inhibitors and potential breast cancer therapeutics
IntroductionMany breast cancer therapeutics target the PI3K/AKT/mTOR oncogenic pathway. Development of resistance to the therapeutics targeting this pathway is a frequent occurrence. Therapeutics targeting p70S6K1, a downstream member of this pathway, have recently gained importance due to its criti...
Saved in:
| Main Authors: | Adrian Thornton, Rajesh Komati, Hogyoung Kim, Jamiah Myers, Kymmia Petty, Rion Sam, Elijah Johnson-Henderson, Keshunna Reese, Linh Tran, Vaniyambadi Sridhar, Christopher Williams, Jayalakshmi Sridhar |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-12-01
|
| Series: | Frontiers in Molecular Biosciences |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmolb.2024.1481912/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Analysis of the measurements used as potency tests for the 31 US FDA-approved cell therapy products
by: Carl G. Simon, et al.
Published: (2025-03-01) -
Development of In Vitro Potency Methods to Replace In Vivo Tests for Enterovirus 71 Inactivated Vaccine (Human Diploid Cell-Based/Vero Cell-Based)
by: Xuanxuan Zhang, et al.
Published: (2025-04-01) -
A systematic analysis of binary blend cement concrete infused with lime sludge and fly ash
by: V.V. Praveen Kumar, et al.
Published: (2024-12-01) -
The stability of human, bovine and avian tuberculin purified protein derivative (PPD)
by: Mailis Maes, et al.
Published: (2011-11-01) -
Measurement uncertainty revealed: The impacts of Certified Reference Material (CRM) on cannabinoid concentrations in the cannabis testing industry
by: Stephen Goldman
Published: (2024-12-01)